Cargando…
Dexmedetomidine Attenuates LPS-Stimulated Alveolar Type II Cells' Injury through Upregulation of miR-140-3p and Partial Suppression of PD-L1 Involving Inactivating JNK-Bnip3 Pathway
Dexmedetomidine (DEX), which is reported to be a newly discovered, novel α-2 adrenoceptor agonist, is known to exhibit anti-inflammatory properties in several diseases. DEX regulates inflammation-related signaling pathways and genes through interactions with several miRNAs. This study verified that...
Autores principales: | Chen, Xianfeng, Hu, Juntao, Lai, Jie, Zhang, Zhiyong, Tang, Zhanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357803/ https://www.ncbi.nlm.nih.gov/pubmed/35958433 http://dx.doi.org/10.1155/2022/8433960 |
Ejemplares similares
-
BNIP3 upregulation via stimulation of ERK and JNK activity is required for the protection of keratinocytes from UVB-induced apoptosis
por: Moriyama, Mariko, et al.
Publicado: (2017) -
BNIP3 decreases the LPS-induced inflammation and apoptosis of chondrocytes by promoting the development of autophagy
por: Ma, Zetao, et al.
Publicado: (2020) -
BNIP3 Upregulation Characterizes Cancer Cell Subpopulation With Increased Fitness and Proliferation
por: Zhu, Yanyan, et al.
Publicado: (2022) -
BNIP3 phosphorylation by JNK1/2 promotes mitophagy via enhancing its stability under hypoxia
por: He, Yun-Ling, et al.
Publicado: (2022) -
JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure
por: Chaanine, A H, et al.
Publicado: (2012)